Researchers report on how exosomic miRNAs released within a tumor environment affect resistance to chemotherapy. Read More
Researchers report they might have discovered why some people are resistant to standard treatments for brain cancer, and it's in their DNA. Read More
A new study reports human neural stem cells show promise for reversing cognitive impairments following chemotherapy. Read More
Researchers suggest delivering chemotherapy directly into the brain cavity could offer a better way to treat tumors which have metastasized to the brain. Read More
A new study provides a possible explanation as to what causes cognitive and memory problems associated with chemotherapy treatments. Read More
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports. Read More
Patients who experience chemobrain after treatment for cancer show brain network disruptions, researchers report. Read More
Brain cancer cells resist therapy by temporarily losing gene mutations targeted by drugs, but re-amplify the mutation once the treatments have stopped, a new study reports. Read More
Researchers confirm the mental fogginess produced as a result of taking the cancer drug tamoxifen, is real. They have also discovered an existing drug compound which appears to counteract the effects of this medication. Read More
A new study argues that prolonged chemotherapy decreases the development of new brain cells, and disrupts ongoing brain rhythms in the part of the brain responsible for making new memories. Read More
Researchers discovered a mutant form of Chk1 gene that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs. This study illustrates an unprecedented finding, that artificially activating Chk1 alone is sufficient to kill cancer cells. Read More
“We identified a subset of brain tumor cells that are slower growing or remain at rest, and appear to be the source of cancer recurrence after standard therapy in which the drug temozolomide is given to stop the tumor’s growth,” said Dr. Luis Parada. “Current therapy targets fast-growing tumor cells but not those responsible for new tumors. To the best of our knowledge, this is the first identification of a cancer stem-like cell in a spontaneously forming tumor inside a mammal.” Read More
